Correlation Between Beta Drugs and HDFC Bank
Specify exactly 2 symbols:
By analyzing existing cross correlation between Beta Drugs and HDFC Bank Limited, you can compare the effects of market volatilities on Beta Drugs and HDFC Bank and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of HDFC Bank. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and HDFC Bank.
Diversification Opportunities for Beta Drugs and HDFC Bank
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Beta and HDFC is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and HDFC Bank Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HDFC Bank Limited and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with HDFC Bank. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HDFC Bank Limited has no effect on the direction of Beta Drugs i.e., Beta Drugs and HDFC Bank go up and down completely randomly.
Pair Corralation between Beta Drugs and HDFC Bank
Assuming the 90 days trading horizon Beta Drugs is expected to generate 2.35 times more return on investment than HDFC Bank. However, Beta Drugs is 2.35 times more volatile than HDFC Bank Limited. It trades about 0.16 of its potential returns per unit of risk. HDFC Bank Limited is currently generating about 0.14 per unit of risk. If you would invest 198,300 in Beta Drugs on September 21, 2024 and sell it today you would earn a total of 14,400 from holding Beta Drugs or generate 7.26% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 95.45% |
Values | Daily Returns |
Beta Drugs vs. HDFC Bank Limited
Performance |
Timeline |
Beta Drugs |
HDFC Bank Limited |
Beta Drugs and HDFC Bank Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Beta Drugs and HDFC Bank
The main advantage of trading using opposite Beta Drugs and HDFC Bank positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, HDFC Bank can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HDFC Bank will offset losses from the drop in HDFC Bank's long position.Beta Drugs vs. Reliance Industries Limited | Beta Drugs vs. Tata Consultancy Services | Beta Drugs vs. HDFC Bank Limited | Beta Drugs vs. Bharti Airtel Limited |
HDFC Bank vs. Lemon Tree Hotels | HDFC Bank vs. SIL Investments Limited | HDFC Bank vs. Advani Hotels Resorts | HDFC Bank vs. Bharat Road Network |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |